5-androstene-3,17-dione has been researched along with malondialdehyde in 1 studies
Studies (5-androstene-3,17-dione) | Trials (5-androstene-3,17-dione) | Recent Studies (post-2010) (5-androstene-3,17-dione) | Studies (malondialdehyde) | Trials (malondialdehyde) | Recent Studies (post-2010) (malondialdehyde) |
---|---|---|---|---|---|
15 | 0 | 1 | 27,849 | 1,405 | 13,922 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hanna, DM; Khalifa, AE; Tadros, MG | 1 |
1 other study(ies) available for 5-androstene-3,17-dione and malondialdehyde
Article | Year |
---|---|
ADIOL protects against 3-NP-induced neurotoxicity in rats: Possible impact of its anti-oxidant, anti-inflammatory and anti-apoptotic actions.
Topics: Analysis of Variance; Androstenedione; Animals; Antioxidants; Apoptosis; Body Weight; Caspase 3; Catalase; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Glutathione; Male; Malondialdehyde; Motor Activity; Neurotoxicity Syndromes; Neurotoxins; Nitric Oxide Synthase Type II; Nitro Compounds; Propionates; Rats; Reflex, Startle | 2015 |